Literature DB >> 22554967

Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance.

Tomonori Kawasaki1, Kunio Mochizuki, Hideko Yamauchi, Shingo Inoue, Tetsuo Kondo, Naoki Oishi, Tadao Nakazawa, Tetsu Yamane, Yoshihito Koshimizu, Hiroko Tsunoda, Hiroshi Yagata, Masayuki Inoue, Ayako Inoue, Takanori Maruyama, Hideki Fujii, Ryohei Katoh.   

Abstract

BACKGROUND: The developmental mechanisms of breast neuroendocrine carcinoma (B-NEC) have not been sufficiently analysed and are not well understood. AIMS: To investigate NE cells in the background tissues surrounding B-NECs.
METHODS: Three cases (four breasts) having many NE cells in the background tissues of multifocal B-NECs were identified at the University of Yamanashi Hospital and St Luke's International Hospital, Japan. These patients were, respectively, 28-, 31- and 38-year-old women with no familial history of NE tumour. The totally-resected breasts were serially studied by immunohistochemistry for specific NE markers (chromogranin A/synaptophysin) and the morphologies and/or localisation of NE cells were investigated.
RESULTS: Immunohistochemical examination showed extensively-distributed NE cells in the background mammary ducts/lobules of the NECs in all breasts. These NE cells were classifiable into three emerging patterns: isolated/scattered, clustered and circumferential. Their distributions were intermingled and were not clearly related to B-NEC foci. NE cells were morphologically polygonal, oval or columnar with sometimes eosinophilic and/or fine-granular cytoplasm and round-to-ovoid nuclei lacking atypia. Some cells were located between epithelial and myoepithelial cells. Apical snouts were occasionally observed in NE cells forming luminal structures.
CONCLUSIONS: Benign-appearing NE cells in the parenchyma of a breast with NEC could be regarded as hyperplastic from their emerging patterns and distribution; this NE cell hyperplasia may be associated with the histogenesis of B-NEC as a precancerous condition. These observations might raise questions about the treatment for B-NEC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554967     DOI: 10.1136/jclinpath-2012-200765

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

Review 1.  Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.

Authors:  Hongna Sun; Shuang Dai; Junnan Xu; Linan Liu; Jiaxing Yu; Tao Sun
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

2.  Clinical and genomic analyses of neuroendocrine neoplasms of the breast.

Authors:  Yani Wei; Xuexuan Ke; Jiaxiu Yu; Qiuyang Jing; Hong Bu; Xiangfei Zeng; Bing Wei
Journal:  Mod Pathol       Date:  2021-11-02       Impact factor: 7.842

3.  Mixed neuroendocrine-non-neuroendocrine neoplasm arising from long-segment Barrett's esophagus showing exceptionally aggressive clinical behavior.

Authors:  Kazuya Miyaguchi; Tomonori Kawasaki; Tomoaki Tashima; Shomei Ryozawa
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-08

4.  Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.

Authors:  David L Wachter; Arndt Hartmann; Matthias W Beckmann; Peter A Fasching; Alexander Hein; Christian M Bayer; Abbas Agaimy
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.